|
|
|
Current Ongoing Clinical Trials at the Comprehensive Transplant CenterLiving Donor Liver Transplantation: Perspectives of General Surgical Residents. Living Donor Liver Transplantation: Perspectives of Potential Living Donors. Correlation of Donor Pro-Inflammatory mRNA Profiles with Early Outcomes of Thoracic and Abdominal Transplantation. The Northwestern Experience with Hepatitis C and Kidney Transplantation: A Center Review. A2ALL: Adult to Adult Living Donor Liver Transplant Study. A2ALL: Adult to Adult Living Donor Liver Transplant Cohort Study- Genomics and Regeneration in the Transplant Setting. Prediction of Hepatitis C Recurrence in Liver Transplant Recipients. Evaluation of Quality of Life Pre and Post Renal Transplant in Hispanic and Non-Hispanic Recipients. B-Cell Depletion by Anti-CD20 (Rituximab) in Renal Allograft Recipients who Develop Early de novo Anti-HLA Alloantibodies will Result in Inhibition of Alloantibody Production & Attenuation of Chronic Humoral Rejection. Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients. A Prospective Long-Term Study of Intestinal Failure Patients and their Donors. Influence of Recombinant Human Growth Hormone (r-HGH) on Intestinal Permeability and Liver Injury in Intestinal Failure Patients Receiving Parenteral Nutrition. Genomics of Chronic Renal Allograft Rejection. Randomized Conversion of Calcineurin-Inhibitors (Tacrolimus to Sirolimus) at 6-24 Months Post Transplant in a Prednisone-Free Immunosuppression Regimen: Impact on Incidence of Acute Cellular Rejection, Renal Allograft Function and T Cell Function. Genetic Predisposition of Chronic Nephrotoxicity from Calcineurin Inhibitors in Liver Transplant Recipients, Potential Correlation with Urinary Biomarkers. The Differential Effects of 3 Different Immunosuppressive agents, Tacrolimus, Mycophenolate, and Sirolimus on the Generation of Tregs and Dcregs in in vitro MLR and T Cell Activation Assays (IS Agents). Living Donor Urinary Biomarkers Measuring Function after Nephrectomy. Urinary biomarkers as Indices of Kidney Recovery Following Cadaveric Renal Transplant with Delayed Graft Function. Islet Transplantation versus Intensive Insulin Therapy in Type 1 Diabetic Kidney Allograft Recipients. Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes. Islet Transplantation in Type 1 Diabetes. A2ALL Human Liver Explants for HIF-1 Alpha Analysis/Comparison. Genes Related to HCC Progression in Living Donor and Deceased Donor Transplant Recipients. A Single-Center Proof of Concept Pilot Study to Evaluate the Safety, Efficacy, and Tolerability of Sorafenib Combined with Therasphere® in Subjects With Hepatocellular Carcinoma Awaiting Liver Transplantation. A Phase IV, Single Center Pilot Study Using Alemtuzumab (Campath-1H) Induction Combined with Prednisone-Free and Calcineurin-Inhibitor-Free Immunosuppression in Kidney Transplantation. Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor Bone Marrow Cell Infusion. Immune Tolerance Profiles after Conversion from Tacrolimus to Sirolimus after Liver Transplant. Evaluation of HepaGam B™ in Combination with Antiviral Treatment in Hepatitis B Liver Transplant Patients. Study of the Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infections. Evaluation of Belatacept as First Line Immunosuppression in De Novo Liver Transplant Recipients. A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients. Delayed Use of Calcineurin Inhibitors and High Dose Mycophenolate Mofetil as Initial Immunosuppressive Therapy for Liver Transplant Recipients with Pre-Transplant Renal Dysfunction. Proteogenomic Monitoring & Assessment of Liver Transplant Recipients. Desensitization for Highly Sensitized Recipients of Pancreas Transplantation. Procurement of Blood Samples from Healthy Volunteers for Immunological Studies. HLA-Identical Sibling Renal Transplant Tolerance with Donor Hematopoietic Stem Cells and Campath-1H. A Phase IV, Single Center, Pilot Study to Assess the Effects of Mycophenolate Mofetil (MMF) on B-Lymphocytes and Dendritic Cells Immunity. A Phase 1, Investigator-Initiated, In-Vitro Standardization of B Cell Elispot Assays. The above studies are adult clinical trials, pediatric clinical trials can be found at: |
 |
|  | ||
| ||||
 | ||||
| ||||
|